Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades-Reference-Cited by-同舟云学术

Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades

Published:2012-06 Issue:7 Volume:62 Page:2184-2191
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Delille Hannah K.,Becker Judith M.,Burkhardt Sabrina,Bleher Barbara,Terstappen Georg C.,Schmidt Martin,Meyer Axel H.,Unger Liliane,Marek Gerard J.,Mezler Mario

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference44 articles.

1. Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release;Aghajanian;Brain Res.,1999

2. Functional crosstalk and heteromerization of serotonin 5-HT(2A) and dopamine D(2) receptors;Albizu;Neuropharmacology,2011

3. A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis;Benneyworth;Mol. Pharmacol.,2007

4. Activation of a dimeric metabotropic glutamate receptor by intersubunit rearrangement;Brock;J. Biol. Chem.,2007

5. Constitutive activity of the cannabinoid CB1 receptor regulates the function of co-expressed Mu opioid receptors;Canals;J. Biol. Chem.,2008

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low prepulse inhibition predicts lower social interaction, impaired spatial working memory, reference memory and cognitive flexibility in genetically heterogeneous rats;Physiology & Behavior;2023-11

2. Preclinical models of treatment-resistant depression: challenges and perspectives;Pharmacological Reports;2023-10-26

3. Molecular and structural insights into the 5‐HT_2C receptor as a therapeutic target for substance use disorders;British Journal of Pharmacology;2023-10-02

4. Progress in metamodulation and receptor-receptor interaction: From physiology to pathology and therapy;Neuropharmacology;2023-10

5. The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia;Biomolecules;2023-08-05